Atypical case of hypermanganesemia with dystonia type 1: a treatable primary dystonia caused by inborn error of manganese metabolism


  • Manish Kumar Department of Pediatrics, Indira Gandhi Institute of Medical Sciences, Patna, Bihar, India



Dystonia, SLC30A10, Hypermanganesemia, T1 hyperintensity, Oral iron therapy


Dystonia is one of the most common movement disorders in the pediatric age group. Dystonia with hypermanganesemia have polycythemia with deranged iron profile, chronic liver disease and basal ganglia hyperintensity on T1 weighted MRI brain image as characteristic finding. We are reporting one case of dystonia, lower limb weakness, polycythemia, and characteristic basal ganglia hyperintensity with a normal iron profile without liver involvement which diagnosed as inherited manganese (Mn) transporter defect due to homozygous mutations of SLC30A10 gene. Most of the reported cases of this mutation have reported decreased iron profile in their blood report and liver involvement contrary to our case. Intravenous disodium calcium edetate chelation and oral iron therapy led to a decrease in whole blood Mn level as well as clinical improvement in the patient. This is a rare disorder and is one of the potentially treatable inherited metal storage disorders and fatal if left untreated.


Fernández-Alvarez E, Nardocci N. Update on pediatric dystonias: etiology, epidemiology, and management. Degener Neurol Neuromuscul Dis. 2012;2:29-41.

Tuschl K, Clayton PT, Gospe SM, Gulab S, Ibrahim S, Singhi P, et al. Syndrome of hepatic cirrhosis, dystonia, polycythemia, and hypermanganesemia caused by mutations in SLC30A10, a manganese transporter in man. Am J Hum Genet. 2012;90(3): 457-66.

Evans GR, Masullo LN. Manganese Toxicity. In: Stat Pearls. Treasure Island (FL): Stat Pearls Publishing; 2022.

Mukhtiar K, Ibrahim S, Tuschl K, Mills P. Hypermanganesemia with Dystonia, Polycythemia and Cirrhosis (HMDPC) due to mutation in the SLC30A10 gene. Brain Dev. 2016;38(9):862-5.

Tavasoli A, Arjmandi Rafsanjani K, Hemmati S, Mojbafan M, Zarei E, Hosseini S. A case of dystonia with polycythemia and hypermanganesemia caused by SLC30A10 mutation: a treatable inborn error of manganese metabolism. BMC Pediatr. 2019;19(1):229.

Marti-Sanchez L, Ortigoza-Escobar JD, Darling A, Villaronga M, Baide H, Molero-Luis M, et al. Hypermanganesemia due to mutations in SLC39A14: further insights into Mn deposition in the central nervous system. Orphanet J Rare Dis. 2018;13(1):28.

Quadri M, Federico A, Zhao T, Breedveld GJ, Battisti C, Delnooz C, et al. Mutations in SLC30A10 cause parkinsonism and dystonia with hypermanganesemia, polycythemia, and chronic liver disease. Am J Hum Genet. 2012;90(3):467-77.

Harischandra DS, Ghaisas S, Zenitsky G, Jin H, Kanthasamy A, Anantharam V, et al. Manganese-Induced Neurotoxicity: New Insights Into the Triad of Protein Misfolding, Mitochondrial Impairment, and Neuroinflammation. Front Neurosci. 2019;13: 654.

Gospe SM, Caruso RD, Clegg MS, Keen CL, Pimstone NR, Ducore JM, et al. Paraparesis, hypermanganesaemia, and polycythaemia: a novel presentation of cirrhosis. Arch Dis Child. 2000; 83(5):439-42.

Kanda T, Nakai Y, Aoki S, Oba H, Toyoda K, Kitajima K, et al. Contribution of metals to brain MR signal intensity: review articles. Jpn J Radiol. 2016;34(4):258-66.

Salari M, Fayyazi E, Mirmosayyeb O. Magnetic resonance imaging findings in diagnosis and prognosis of Wilson disease. J Res Med Sci. 2018; 23:23.

Lee JH, Yun JY, Gregory A, Hogarth P, Hayflick SJ. Brain MRI pattern recognition in neurodegeneration with brain iron accumulation. Front Neurol. 2020;11:1024.

Yapici Z, Tuschl K, Eraksoy M. Hypermanganesemia with Dystonia 1: A Novel Mutation and Response to Iron Supplementation. Mov Disord Clin Pract. 2019;7(1):94-6.






Case Reports